Update on COVID-19 vaccines and CML
Join our two experts as they discuss key aspects on COVID-19 vaccines for patients with CML.
COVID-19 vaccine overview: Professor Steve Wesselingh, from the South Australia Health and Medical Research Institute, Adelaide (Australia)
COVID-19 vaccines for patients with CML: Dr Kendra Sweet, Haematologist at the MOFFITT Cancer Center and Research Institute, Tampa (USA)
Professor Steve Wesselingh, an Infectious Disease physician and researcher in Neurobiology, HIV and vaccine development will provide an overview of the different types of COVID-19 vaccines currently in use around the world.
As a haematologist, Dr Kendra Sweet will then put this into perspective for CML.
She will share current experience with COVID-19 vaccines in patients with CML and provide guidance on how to best manage patients with CML.
- Date: Wednesday, April 7th at 13.30 Central European Time (CET)
- How can I dial into the webinar?
- Please join this meeting from your computer, tablet or smartphone via the link: https://us02web.zoom.us/j/84473245408
- Meeting-ID: 84473245408
- At what time does the webinar take place in my time zone?
The webinar will be held from 13.30 – 14.15 Central European Time.
Times in other times zones:
ACST – Australian Central Standard Time: 21.00
BRT – Brazilian Time: 08.30
CAT – Central African Time: 13.30
CST – China Standard Time: 19.30
EAT – East Africa Time: 14.30
EST – Eastern Standard Time: 07.30
GMT – Greenwich Mean Time: 12.30
IST – Indian Standard Time: 17.00
If you have any questions or need assistance, please email to firstname.lastname@example.org
- Can I ask questions during the webinar?
An important part of the conversation will be questions from the audience. You can submit your questions via chat during the webinar and the experts will answer as many as possible during the Q&A session.
- Can I watch the webinar at a later time?
The webinar will be made available on the iCMLf website after the event.